STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 70 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 2.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $486,000 | -71.8% | 43,749 | -76.7% | 0.03% | -71.7% |
| Q2 2017 | $1,725,000 | -30.4% | 187,500 | -35.4% | 0.11% | -15.7% |
| Q1 2017 | $2,480,000 | -35.2% | 290,087 | -18.9% | 0.13% | -39.9% |
| Q4 2016 | $3,829,000 | +260.5% | 357,806 | +264.9% | 0.22% | +457.5% |
| Q3 2016 | $1,062,000 | -20.4% | 98,050 | +44.0% | 0.04% | -52.9% |
| Q4 2013 | $1,335,000 | – | 68,100 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|